Expanded GGGGCC (G4C2) nucleotide repeats within the C9ORF72 gene are the most common genetic mutation associated with both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Sense and antisense transcripts of these expansions are translated to form five dipeptide repeat proteins (DRPs). We employed primary cortical and motor neuron cultures, live-cell imaging, and transgenic fly models and found that the arginine-rich dipeptides, in particular Proline-Arginine (PR), are potently neurotoxic. Factors that anticipated their neurotoxicity included aggregation in nucleoli, decreased number of processing bodies, and stress granule formation, implying global translational dysregulation as path accountable for toxicity. Nuclear PR aggregates were also found in human induced motor neurons and postmortem spinal cord tissues from C9ORF72 ALS and ALS/FTD patients. Intronic G4C2 transcripts, but not loss of C9ORF72 protein, are also toxic to motor and cortical neurons. Interestingly, G4C2 transcript-mediated neurotoxicity synergizes with that of PR aggregates, suggesting convergence of mechanisms.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS), a motor neuron degenerative disease (Kiernan et al., 2011) , and frontotemporal dementia (FTD), a presenile onset dementia characterized by selective degeneration of frontal and temporal lobes (Warren et al., 2013) , appear to be manifestations of the same clinicopathological spectrum Elamin et al., 2013; Phukan et al., 2007 Phukan et al., , 2012 . The recent identification of aberrant GGGGCC (G4C2) intronic repeat expansions in the C9ORF72 gene (DeJesus-Hernandez et al., 2011; Renton et al., 2011) as the most common cause for both ALS and FTD have further emphasized this notion (Majounie et al., 2012) . C9ORF72 patients carry from tens to hundreds of G4C2 repeats, while the majority of unaffected individuals have no more than 2 to 25 repeats (Rutherford et al., 2012) . Correlation between these expanded repeats and severity of clinical manifestations has yet to be established.
Repeat expansions in genes cause many hereditary diseases in humans (La Spada and Taylor, 2010) . The mechanisms by which G4C2 repeat expansions cause neurodegeneration are under intense investigation. Decreased C9ORF72 mRNA expression levels were detected in C9-ALS/FTD patient lymphoblasts (DeJesus-Hernandez et al., 2011) . This led to the hypothesis that the intronic expansions could cause downregulation of the C9ORF72 protein, which could then be responsible for neurodegeneration. Support for this loss-of-function hypothesis was first reported in zebrafish (Ciura et al., 2013) , although confirmation is still lacking in mammalian models.
Lines of evidence supporting a gain-of-toxic-function hypothesis of pathogenesis have recently started to emerge. For instance, sense and antisense G4C2 repeat RNA transcripts accumulate in nuclear foci in neurons of different CNS areas of C9-ALS/FTD patients (Zu et al., 2013) ; antisense oligonucleotides against C9ORF72 transcripts reduced RNA-binding protein sequestration and increased glutamate sensitivity of neurons derived from induced pluripotent stem cells (iPSCs) of C9-ALS patients (Donnelly et al., 2013) ; and G4C2 repeat expansions adopt stable G-quadruplex motifs (Reddy et al., 2013) , which sequester ribonucleoproteins critical for cell survival (Haeusler et al., 2014) . Furthermore, repeat-associated, non-ATG initiated (RAN) translation has been reported in several nucleotide repeat disorders (Zu et al., 2011) . RAN-translated proteins from sense and antisense transcripts were reported accumulating in C9-ALS/FTD tissues (Ash et al., 2013; Mori et al., 2013) , implying a pathogenic role for these proteins. Indeed, some of these RANtranslated proteins were recently described to cause toxicity (Kwon et al., 2014; Zhang et al., 2014) . All of the different and potentially toxic instances appear not to be mutually exclusive, as evidence for their coexistence was found in postmortem patient samples (Gendron et al., 2013a) . However, it remains challenging to tease out their individual contributions and mechanisms of toxicity.
We were able to independently model these different C9ORF72 pathogenic instances. By transfecting cortical and motor neurons with constructs engineered by a randomized codon strategy to express C9RAN proteins avoiding GC repeat sequences, or constructs encoding intronic expanded G4C2 sequences that do not initiate RAN translation, and constructs that efficiently knock down C9ORF72, we deciphered by means of time-lapse live-cell imaging their respective impact on neuronal viability. We also established transgenic Drosophila models of C9RAN proteins. We found that one of the antisense C9RAN proteins, the Proline-Arginine dipeptide (PR), is potently neurotoxic when expressed in vivo and neurons with nuclear PR aggregates have a much higher risk to undergo degeneration. In addition, induced motor neurons (iMNs) derived from C9-ALS patients showed intranuclear PR + aggregates, increased number of extracellular PR aggregates in the dish, and dramatic decrease in survival compared to controls. Nuclear PR aggregates were also found in human spinal cord tissues from C9ORF72 ALS/ FTD patients. Interestingly, we found that poly-PR peptides aggregate in nucleoli, causing enlargement of the nucleolus, cell stress responses, and ultimately cell death. In PR-expressing neurons, death is preceded by a decreased number of RNA-processing bodies (P-bodies) and by the appearance of cytosolic stress granules. These findings suggest that nuclear aggregation of PR peptides initiates a cascade of events leading to neurodegeneration via global perturbation in RNA processing and posttranscriptional regulation of gene expression.
RESULTS

RAN Translated Poly-PR Proteins Are Neurotoxic
In vivo, pathogenic intronic G4C2 repeat expansions undergo RAN translation on both sense and antisense transcripts using all reading frames, giving rise to five dipeptide repeat proteins (DRPs) of presumably variable length (antisense: poly-PR and poly-PA; sense: poly-GA and poly-GR; both sense: poly-GP) (Ash et al., 2013; Gendron et al., 2013b; Mori et al., 2013; Zu et al., 2013) . DRPs form aggregates in C9 patients in different neurons, including those not affected by disease (Gendron et al., 2013a; Zu et al., 2013) . It remains an open question whether and which DRPs initiate toxicity in neurons. To decipher the neurotoxic profiles of the various DRPs, we transfected mouse motor neuron-like NSC34 cells, as well as primary cortical and motor neurons, with DRP-encoding constructs of different lengths (25-to 400-dipeptide-long sequences) tagged with GFP to aid identification of transfected cells. Constructs were designed to express DRPs in an ATG-dependent translation and with a randomized codon strategy to ensure expression of only the chosen DRP sequence at the desired length. This approach allowed us to engineer stable constructs containing moderate GC content encoding up to 400-dipeptide-long repeats for GR and GA, 200 for PR and PA, and 50 for GP and to avoid potential toxicity induced by G4C2 repeats expansion at transcript level ( Figure S1 available online).
Proper expression of DRP constructs in NCS34 cells was assessed by western blot analysis using anti-DRPs (Ash et al., 2013) (Figure S2A ) and GFP antibodies. Notably, the argininerich dipeptides, PR and GR, were consistently expressed at somewhat lower levels, whereas expression levels of the other DRPs were comparable ( Figure S2B ). Confocal microscopy analysis showed distinct PR and GR nuclear aggregates, whereas GA-and PA-expressing cells revealed predominant cytoplasmic aggregates. Conversely, GP displayed diffused localization ( Figure S2C ). The different DRPs had analogous localization patterns when transfected in cortical and motor neurons (Figures S2D and S2E) .
We next sought to evaluate toxicity by longitudinal, live-cell imaging that gauged survival of DRP-expressing neurons. Mature cortical neurons (10 days in vitro [DIV10]) (Lesuisse and Martin, 2002) were cotransfected with GFP-tagged DRP constructs and Td-Tomato reporter driven by the synapsin promoter. This aided live visualization of transfected neurons ( Figures S3A, S3B , and S3C). The same GFP + and Td-tomato + cortical neurons were followed at 24 hr intervals, up to several days posttransfection. Expression of PR 50 dramatically decreased cortical neuron survival ( Figure 1A ), while the other four DRPs did not (Figure 1B) . Most of PR 50 -mediated cell death occurred in the first 72 hr posttransfection. Interestingly, image analysis revealed that the majority of neurons harboring PR nuclear aggregates died within 24-48 hr after aggregates formed, while neurons featuring diffused pattern of PR expression survived ( Figure 1C ). This was confirmed by Kaplan-Meier survival and risk-of-death analysis performed on cohorts of neurons displaying either nuclear aggregates or diffused localization ( Figure 1D ). PR neurotoxicity did not significantly vary with increased length of repeats ( Figure 1E ), and the effect appeared to be concentration dependent ( Figure 1F ). Clear length-dependent neurotoxicity was instead seen for poly-GR. Conversely, poly-PA, GA, and GP were not significantly, or just marginally (poly-PA), toxic at the longest lengths tested. Expression levels were comparable among the DRPs of different lengths (Figure 1G) . PR 50 was also toxic to primary motor neurons. However, these neurons were equally susceptible to expression of GR 50 (Figures S4A and S4B) , which aggregated in the nucleus, similarly to PR 50 although less aggressively (Figures S2 and S4B) . Notably, hippocampal neurons, which are marginally affected in C9-FTD (Warren et al., 2013) , were also vulnerable to PR toxicity, but to a much lesser extent than cortical neurons and despite comparable expression levels, assessed as intensity of GFP fluorescence signal ( Figures S4C, S4D , and S4E). Localization pattern of PR and extent of its toxicity did not depend on the presence of the GFP tag in the dipeptide sequence as the expression of untagged PR 50 displayed similar toxic and localization profile as the GFP-tagged dipeptide (Figures S4F, S4G, and S4H) . In contrast to the toxic effect of PR 50 on both cortical and motor neurons, we found that SOD1-G93A displayed selective toxicity toward motor neurons (Figures S4I and S4J) . This observation is consistent with the fact that the SOD1-G93A mutation causes pure ALS with no FTD symptoms.
Neuronal Death by Intronic G4C2-Containing Transcripts It was recently shown that expanded G4C2 repeats are toxic to neuronal cell lines and zebrafish embryos (Lee et al., 2013) . A still open question is whether G4C2 repeat expansions, harbored in an intronic sequence, cause neurodegeneration independently of the C9ORF72 gene sequence. We generated plasmids containing 0, 21, and 42 G4C2 repeats (R0, R21, R42) in an artificial intronic sequence inserted between two EGFP exons ( Figures  S5A and S5B ) and transfected primary cortical neurons. These neurons could be readily identified for live-cell imaging by the concomitant Td-tomato and GFP fluorescence ( Figure S5C ). GFP expression was confirmed by western blot analysis of lysates of R0-R42-transfected NSC34 cells probed with an anti-GFP antibody ( Figure S5D ). Expression of the G4C2 transcripts was verified by fluorescence in situ hybridization (FISH) analysis ( Figure S5E ), which revealed prevalent nuclear localization of the (E) Length-dependent toxicity of DRPs in cortical neurons. Poly-GR displayed clear length-dependent toxicity (**p < 0.01; one-way ANOVA), whereas the effect of poly-PR already peaked at 25 repeats, displaying no significant length dependency (one-way ANOVA). Data are shown as mean ± SEM. (F) Cortical neuron toxicity of PR 50 diminished as amount of transfected cDNA was reduced, suggesting a dose dependency in the effect. Maximum amount of cDNA-PR 50 transfected was 0.8 mg/well (100%). Total amount of DNA transfected was kept constant across groups (1 mg/well). *p < 0.05. Data are shown as mean ± SEM. (G) NSC34 cells were transfected with indicated constructs. Expression levels of different lengths of DRP constructs were assessed using dot blots. Actin was used as a loading control. Comparable expression levels were observed for DRPs of different lengths.
G4C2 RNA transcript signal in cells transfected with R21 and R42 but not with R0.
Longitudinal live-cell imaging analysis showed that R42-transfected cortical neurons survived significantly less than R0-or R21-expressing neurons (Figure 2A ). The risk of death increased 2-fold ( Figure 2B ). R42 construct displayed dose-dependent toxicity with a threshold effect seen at 50% of the amount of transfected cDNA ( Figure 2C ). R42-expressing motor neurons had higher risk of death compared to R21 and controls ( Figures  2D and 2E ), whereas survival of hippocampal neurons was not affected by the R42 transcript ( Figure 2F ).
G4C2
Repeats Neurotoxicity Is Independent on RAN Translation RNA sequence made of 38 G4C2 repeats can initiate RAN translation when expressed in HEK cells in a repeat length-dependent (B and C) Kaplan-Meier survival and cumulative risk of death analysis of cortical neurons transfected with R0, R21, or R42 showed that expanded intronic G4C2 repeats caused cell death and significantly increased the risk of death. Neurotoxicity of G4C2 decreased with reduced amount of R42 cDNA transfected into neurons, suggesting dose dependency. Note that 50% of R42 cDNA (or 0.4 mg) is not sufficient to cause toxicity. Total amount DNA used in transfection remained the same across groups. At least 80 neurons were followed/group; n = 3 experiments. *p < 0.05, **p < 0.01, ***p < 0.001. manner (Mori et al., 2013) . To determine whether R42 neurotoxicity in our culture systems was mediated by RAN translation, we performed western blot analysis on lysates of R0-R42-transfected motor neuron-like NSC34 cells using antiDRPs antibodies. We found no evidence for formation of any of the five possible DRPs ( Figure 3A ). This was further confirmed in cortical neurons transfected with R42 by immunocytochemistry and dot blot analysis ( Figures 3B and 3C ). While intronic R42 repeats do not produce detectable DRPs, we found that the concomitant expression of a subtoxic concentration of R42 repeat transcripts (50% of the dose normally used) greatly enhanced the damaging effect of a marginally toxic concentration (50% of the dose) of PR 50 on cortical neurons ( Figure 4A ). On the other hand, the prevalently cytosolic expression of GA aggregates in combination with R42 did not produce the same synergistic effect ( Figure 4B ).
Recently, nucleolar stress was proposed as a potentially toxic mechanism of the G-quadruplexes formed by G4C2 transcripts (Haeusler et al., 2014) . Interestingly, PR aggregates colocalized with nucleolin, a constituent protein of nucleolus. PR-containing nucleoli appeared larger in size with dispersal of nucleolin staining, suggesting PR-mediated dynamic nucleolar stress response (Figures 4C, 4D, S6A, and S6B) . PR aggregates colocalized with fibrillarin, another protein constituent of nucleolus (Ochs et al., 1985) , confirming their nucleolar partition (Figures S6C and S6D) . Similar aggregation in nucleoli was seen for GR 50 , even though a good portion of them were still retained in the cytosol ( Figure S6E ). We observed that neurons with nuclear PR aggregates had a consistent reduction in the number of cytosolic P-bodies ( Figure 4E ), which featured larger size on average (Figure 4F) , and formed stress granules ( Figure 4G ).
Knockdown of C9ORF72 Does Not Affect Neuronal Survival In Vitro
Studies of familial C9 patients have reported an approximately 50% reduction in C9ORF72 mRNA levels (DeJesus-Hernandez et al., 2011; Renton et al., 2011) , hypermethylation of these repeats and the neighboring CpG islands (Xi et al., 2013) , suggesting haploinsufficiency as the possible initiating mechanism of neurodegeneration.
To test whether C9ORF72 is critical for neuronal survival, we characterized an shRNA-GFP construct to efficiently knock down C9ORF72 in cortical and motor neurons. This approach also allowed the optimization of a commercially available anti- Equal amounts of protein were loaded and actin was used as a loading control. Dot blot analysis suggests that no DRPs were generated from cortical neurons expressing R0, R21, and R42.
C9ORF72 antibody. The antibody detected C9ORF72 isoform a and b (Woollacott and Mead, 2014) when their respective Flag-C9ORF72 cDNAs were transfected in HEK293 cells ( Figure 5A ). The antibody also detected endogenous C9ORF72a but not C9ORF72b isoform ( Figure 5A ). This antibody was then used to confirm specific knockdown of C9ORF72a with the shRNA construct ( Figure 5B ). Because the shRNA sequence targets both C9ORF72 isoforms, the successful knockdown of the endogenous isoform a (R70%) can imply a similar outcome for isoform b. The fact that the antibody could not detect endogenous C9ORF72b, despite the fact that the antibody was recognizing both overexpressed isoforms with similar affinity, suggests that C9ORF72a is the dominant isoform ( Figure 5A ). When we used this antibody to probe the expression levels of C9ORF72 in human lymphoblast lines derived from C9-ALS/FTD patients, we found that expression levels of C9ORF72a was decreased by 50% compared to controls ( Figure 5C ).
The sequence targeted by our shRNA construct is conserved among human, mouse, and rat, so we could efficiently knock down C9ORF72 in primary cortical neurons as well. Immunocytochemistry analysis of NSC34 cells transfected with C9ORF72 cDNA tagged with Flag and Myc sequences showed prevalent cytosolic staining of C9ORF72 ( Figure 5D ). The cytosolic localization of C9ORF72 was further confirmed by immunocytochemistry analysis of cortical neurons transfected with C9ORF72-shRNA construct ( Figure 5E ).
To address whether downregulation of C9ORF72 expression would lead to neuronal death, we transfected primary rat cortical Neuron Toxicity of C9RAN Peptides and G4C2 Transcripts neurons with C9ORF72 shRNA-EGFP or scrambled shRNA constructs as control. Cortical neurons were cotransfected with the synapsin promoter-driven Td-Tomato reporter construct for livecell imaging. Survival curves of cortical neurons treated with shRNA or control scrambled shRNA were not statistically different ( Figure 5F ). Similarly, C9ORF72 knockdown did not affect survival of rat primary motor neurons ( Figure 5G ), indicating that C9ORF72 loss of function is not a primary cause of neurotoxicity in C9-ALS/FTD.
Ectopic Expression of C9RAN-Translated PR 50
Dipeptide Leads to Neurodegeneration in Drosophila melanogaster An in vivo model was recently developed to investigate the toxicity of expanded hexanucleotide transcripts. These transcripts caused progressive neurodegeneration in the eye and motor neurons of Drosophila (Xu et al., 2013) . We wanted to investigate whether C9RAN PR dipeptides could also lead to a neurodegenerative phenotype in vivo and, therefore, generated transgenic flies overexpressing flag-EGFP-tagged PR 50 . We also generated transgenic flies expressing GA 50 and PA 50 because, despite these DRPs lack in vitro toxicity, they displayed quite distinctive localization patterns, which could possibly result in a neurotoxic profile in vivo. These transgenes were inserted by PhiC31 integration at the exact same genomic locus and are therefore transcribed equally.
We found that targeted expression of PR 50 caused severe neurodegeneration in Drosophila eyes ( Figure 6A ). PR 50 expression was not detectable by western blot analysis of the eye in PR 50 flies, presumably due to massive loss of the eye neurons. Expression of mRNA of the DRP transgenes was verified in the prepupae stage and found to be statistically not different among the different fly lines, suggesting that the toxicity was not to be ascribed to difference in DRP expression levels ( Figure 6B ). On quantitation of the eye phenotype using our previously published criteria (Lanson et al., 2011; Pandey et al., 2007) , the ommatidia appeared to be completely degenerated in flies ectopically expressing PR 50 , with loss of mechanosensory bristles and loss of pigmentation, whereas expression of GA 50 , PA 50 , or flag-EGFP control resulted in no obvious external eye degeneration ( Figures 6A and 6C) .
In order to understand the consequences of PR 50 in the motor system, we targeted the expression of these poly-peptides to motor neurons using the OK371-GAL4 driver. Contrary to the other genotypes or control, PR 50 expressors did not develop to adulthood ( Figure 6D ). They fully developed to the pupal stage and appeared morphologically normal, but we found that they were unable to escape out of the pupal case, whereas flies expressing GA 50 , PA 50 , and control construct were able to escape normally. These PR 50 -expressing flies had no movement and did not survive. Dissecting the PR 50 -expressing flies from their pupal case, we found that these flies had no obvious defects other than what could be expected from being paralyzed with folded wings and legs, wet appearance and no movement ( Figure 6E ). Similarly to the eye expressor line, PR 50 could not be detected by western blot analysis presumably due to massive loss of motor neurons. We, therefore, verified expression of the DRP transgenes by qPCR at the larvae stage of the transgenic flies and found that there was statistically no difference in the DRP mRNAs in the different lines ( Figure 6F ). Furthermore, we drove expression in muscles using MHC-GAL4 driver and confirmed effective expression and similar expression levels of the different C9RAN peptides by western blot analysis, with GA 50 dipeptides often found in the stacking gel ( Figure 6G ). To confirm the subcellular localization pattern of the DRPs, we used anti-lamin antibody to stain the nuclear envelope in the Drosophila larvae neural tissue. Thus, staining inside the lamin ring is nuclear and outside the ring is cytoplasmic (Daigle et al., 2013; Lanson et al., 2011) . We found that GA 50 concentrated in perinuclear or cytosolic aggregates, while PA 50 and GFP control displayed diffuse cytosolic localization. Similarly to cultured neurons, PR 50 was predominantly aggregated in nuclei ( Figure 6H ).
PR Aggregates Are Toxic to Human iPSC-Derived
Neurons and Are Present in C9ORF72 ALS Patient-Derived Human Induced Motor Neurons and Postmortem Spinal Cord Tissues To establish whether expression of PR was also toxic to human neurons, we transfected human iPSC-derived generic neurons with PR 50 , GA 50 , or control constructs. Transfection efficiency of the constructs in these neurons was somewhat lower than the one we achieved for rat primary neurons. Nevertheless, we were able to build Kaplan-Meier survival curves and hazard analysis for each experimental group and found that PR 50 was potently toxic, whereas neurons expressing GA 50 at similar levels had a cumulative risk of death nonsignificantly different from the control transfected group ( Figure 7A) . Similarly to what was reported for rat primary neurons, we found PR 50 aggregates colocalized with nucleolin in nucleoli ( Figure 7B ). To determine whether PR aggregates are relevant to the human disease state, we determined whether PR nuclear aggregates were also endogenously expressed by induced motor neurons from C9ORF72 ALS patients. We used transcription factor-mediated lineage conversion (Son et al., 2011) to generate induced motor neurons (iMNs) from iPSCs of C9ORF72 ALS patient and unaffected control. In both patient and control cultures, we observed cells with mature neuronal morphologies that expressed Hb9 and TuJ1, confirming their motor neuron identity ( Figure 7C ). The iMNs were labeled with an Hb9::Channelrhodopsin-YFP reporter lentivirus (Marchetto et al., 2008) . In control iMN cultures, we rarely observed intranuclear PR + aggregates, suggesting a low level of PR production in these cells. Similarly, we observed intranuclear PR + aggregates in C9-ALS iMNs ( Figure 7D ). However, in contrast to control cultures, C9-ALS cultures contained a high number of extracellular PR + aggregates, and significantly 
Neuron
Toxicity of C9RAN Peptides and G4C2 Transcripts fewer iMNs survived in C9-ALS cultures after extended periods, indicating that they undergo accelerated neurodegeneration relative to control iMNs ( Figures 7E and 7F ). Interestingly, we also detected extracellular PR aggregates in primary cortical and motor neuron cultures transfected with PR-expressing constructs. Live-cell imaging showed that PR aggregates remained attached on the bottom of the dish once the PR-expressing neurons (either motor or cortical neurons) lost membrane integrity and died ( Figures 1C, S4A , and S7). Overall, these results demonstrate that human C9-ALS-derived motor neurons produce elevated levels of PR. Moreover, the presence of large numbers of extracellular PR + aggregates and reduced numbers of iMNs in C9-ALS patient cultures agree with results in rodent cultures. Confocal microscopy analysis of spinal cord tissues from C9-ALS and C9-ALS/FTD patients revealed the presence of PR + nuclear as well as extranuclear inclusions ( Figure 8A ). Notably, PR + aggregates were rarely detected in control nondiseased spinal cords and, even less, in non-C9 spinal cords ( Figures 8B and  S8C ). In PR + nuclei, poly-PR either aggregated in a relatively large nuclear area or they formed punctate aggregates that colocalized with nucleophosmin in nucleoli ( Figures 8C and S8D ). Nuclei-containing PR aggregates often appeared smaller and shaped irregularly compared to the well-rounded nuclei of the control tissue, suggesting nuclear stress ( Figure 8A ).
DISCUSSION
Pathological findings in cells and tissues of C9ORF72-linked ALS/FTD patients suggest three possible pathogenic mechanisms of disease. The presence of RNA foci and accumulation of RAN-translated proteins suggests an RNA-gain of function or an RAN translation-induced toxicity. The evidence that cells derived from C9ORF72 patients have decreased levels of C9ORF72 transcripts suggests instead a loss-of-function mechanism. Increasing lines of evidence point at RNA gain of function and RAN translation as the most likely mechanisms (Donnelly et al., 2013; Gendron et al., 2013b; Haeusler et al., 2014; Zu et al., 2013) . However, whether one mechanism predominates over the other or whether they both contribute to neurodegeneration is not clear. Similarly, it remains unknown whether there are neuronal-specific RAN toxic species. Recent studies showed that arginine-rich RAN dipeptides were cytotoxic by impairing the biogenesis of ribosomal RNA when nonneuronal cells (i.e., astrocytes and immortalized cell lines) were incubated with the synthetic peptides (Kwon et al., 2014) . Toxicity of these arginine-rich peptides was also shown in vivo, in Drosophila models (Mizielinska and Isaacs, 2014) . Another study showed, instead, that a different RAN-translated species, poly-GA, caused toxicity measured by increased release of LDH, caspase-3 activation, and endoplasmic reticulum stress when expressed in cultured cells and primary neurons (Zhang et al., 2014) . Here, we extended these findings by employing a systematic approach to determine the specific contribution to neurotoxicity of each of the three C9ORF72-related pathological instances using disease-relevant human and rat neuronal cultures coupled to longitudinal live-cell tracking imaging, as well as Drosophila models. We provided clear evidence that: (1) among all the possible C9RAN-translated dipeptides, the arginine-rich antisense transcript-encoded PR, and the sense transcript-encoded GR are the neurotoxic species, with GR, but not PR, showing a repeat length-dependent toxicity, whereas PR full toxicity was already manifested at the lowest repeat length tested; (2) arginine-rich C9RAN dipeptide toxicity follows their nuclear aggregation; (3) the arginine-rich dipeptides aggregate in nucleoli, causing a stress-response in cells, with a reduction in the number of processing bodies and formation of stress granules; (4) intronic G4C2 transcripts, but not loss of C9ORF72, are also toxic to motor and cortical neurons; (5) G4C2 neurotoxicity is independent from the appearance of RAN pathology, although the neurotoxic effects of intronic G4C2 transcripts synergize with that of PR aggregates. Finally, we demonstrated that the equal sensitivity of cortical and motor neurons to C9ORF72 is mutation specific. The initiation of RAN translation is thought to depend on RNA hairpin structures that utilize GC pairing (Zu et al., 2011) . A recent study demonstrated that an RNA sequence of 38-G4C2 repeats is sufficient to initiate this unconventional translation in a cell line (Mori et al., 2013) . In the time frame of our experiments, we did not detect C9RAN DRPs in neurons expressing R42 transcripts, albeit the 42-G4C2 hexanucleotide repeats were properly expressed. This lack of RAN translation and DRP pathology suggested that RAN translation might require selective, still unknown, stressors to occur and provided us a suitable in vitro model to test the neurotoxic profile of G4C2 transcripts and DRPs independently from one another.
Intronic G4C2 transcripts and PR dipeptides are both sufficient to induce death of both cortical and motor neurons in a dose-dependent manner. However, subtoxic or threshold toxic concentrations of R42 transcripts and PR dipeptides exhibit neurotoxic synergy when coexpressed in the same neurons. This opens up the possibility that C9ORF72 products, being Gquartets formed from sense C9 transcripts (Haeusler et al., 2014) or RAN-translated PR dipeptides formed from antisense C9 transcripts could converge toward the same mechanism(s). More studies are needed to tease out the many possible toxic combinations that could originate from C9 transcripts and, more importantly, to determine what triggers them. Of the five possible C9RAN dipeptides tested, only the arginine-rich PR and GR were neurotoxic. They were also the only two DRPs with a nuclear localization profile. In particular, the risk of death of neurons expressing PR considerably increased if nuclear aggregates were present. PR nuclear aggregation was confirmed both in human induced motor neurons derived from iPSCs and in postmortem spinal cord tissue of C9-ALS patients. Moreover, aggressive toxicity and nuclear aggregation phenotype were also seen in human iPSC-derived neurons from nondiseased individual transfected with PR 50 and in vivo in a Drosophila model. Thus, our data suggested that the arginine-rich poly-peptides are the key toxic C9RAN products in C9-ALS/FTD. Live-cell imaging analysis showed that PR aggregates are stable and persist in the dish long after the neuron has died. Interestingly, we observed that in induced motor neuron cultures derived from C9 patients, there was an increased number of extracellular PR aggregates in the dish, which paralleled increased cell loss relative to control cultures, suggesting that PR-bearing C9 patient neurons did not survive in culture and the cells underwent a selection process. In line with recently reported histopathological analysis of DRP formation in postmortem CNS tissues of C9-ALS/ FTD patients, our risk of death analysis underscores PR strong neurotoxic potential and predicts that only evidence of nontoxic DRP formation may be preponderant in the postmortem tissue. It is, therefore, not surprising that PR aggregates have been seldom found in postmortem diseaseaffected tissue of C9 patients. On the other hand, GA, GR, PA, and GP inclusions, which are mild or not neurotoxic in our assays, have been found throughout different CNS areas, including those not affected by disease (Gendron et al., 2013a (Gendron et al., , 2013b Zu et al., 2013) . Nonetheless, we provided here clear evidence for PR nuclear aggregates, including instances of nucleolar localization, in spinal cord tissues of C9-ALS patients. Similarly, Pickering-Brown and colleagues found evidence of PR proteins that displayed strong immunoreactivity of chromatin in pyramidal cells of the hippocampus, suggesting nuclear localization of the PR polypeptides (Mann et al., 2013) . Whether PR aggregation is cell type specific in the human disease context remains to be further examined.
Our studies differentiated the possible role of RAN dipeptides in disease. While GA, GR, PA, and GP could represent pathological hallmarks detectable in surviving neurons, PR is the pathogenic candidate whose presence predisposes neurons to quickly degenerate and die. For disease-relevant mechanisms, the predictive nature of our culture assay is also validated by the cell and mutation specificity of our findings. Hippocampal neurons, which are seemingly less affected in C9-FTD and C9-ALS/FTD, are also significantly less sensitive to PR toxicity in cultures. Resilience to PR and/or R42 toxicity in cells not affected by disease and the mutant-specific vulnerability of different neuronal types implied the occurrence of molecular pathways capable of defining disease phenotypes. The message that different cells respond differently to the same toxic insults and that pathological markers do not necessarily correlate with disease pathogenesis underscores the importance of dissecting disease mechanisms, even in relatively simple systems. The knowledge could be critical when identifying relevant and specific therapeutic targets.
But the most pressing question for the development of therapies aimed at stopping or even preventing neurotoxicity is how PR or, more in general, arginine-rich expanded poly-dipeptides give rise to neurodegeneration. Different groups have reported evidence for alterations in translational control of gene expression, characterized by alterations in P-bodies and appearance of stress granules (SGs) in cell models of neurodegenerative disease (Nonhoff et al., 2007; Savas et al., 2008) . In this respect, an interesting parallel can be drawn with the neurotoxicity of PR dipeptides. In neurons with nuclear PR aggregates, we found a significant reduction in the number of P-bodies concomitant to increased size average and the appearance of SGs. These RNA granules are silencing foci as they typically harbor transcripts circumstantially excluded from the translationally active pool (Thomas et al., 2011) . P-bodies are constitutive but respond to stimuli that affect mRNA translation and decay. SGs are specifically induced upon cellular stress, which triggers a global translational silencing of several pathways. Various changes in cell physiology are able to affect these RNA granules in size and numbers. At this point of our investigation, however, it is not possible to establish a firm temporal sequence of events leading to neurodegeneration as there is not enough functional data to support dysregulation of RNA granules as the leading mechanism of PR aggregate toxicity.
Interestingly, P-body dysregulation may result from nucleolar stress (Kedersha et al., 2008) . We found that PR aggregates aberrantly accumulate in the nucleolus, which appears enlarged. Nucleoli control ribosome biogenesis and protein trafficking under cellular stress (Nalabothula et al., 2010) . Thus, in the case of PR-containing neurons, where the nucleolus is enlarged and the number of P-bodies reduced, it is tempting to hypothesize PRinduced nucleolar stress as the mechanism that marks neurons destined to degenerate. Similarly to what we found here for PRmediated neurotoxicity, Wang and colleagues have recently proposed nucleolar stress followed by alterations in P-bodies as possible mechanism(s) for G4C2 hexanucleotide repeat expansions toxicity (Haeusler et al., 2014) . Additionally, the synergistic neurotoxic effect between R42 transcripts and PR dipeptides points at nucleolar stress as a converging mechanism between these two toxic insults.
Overall, the data presented here support a gain-of-function mechanism of C9ORF72-ALS/FTD toxicity and identify relevant toxic species in this gain-of-function pathway(s). Loss of C9ORF72 function achieved by knockdown approach did not impact survival of both cortical and motor neurons, suggesting that loss of C9ORF72 function may not be one mechanism contributing to neurodegeneration. However, we do not know what could be the impact on neurons of knocking down C9ORF72 over the timescale of the human lifetime. Therefore, we cannot exclude for sure the loss-of-function hypothesis as one mechanism contributing to neurodegeneration in C9-ALS/FTD.
The identification of C9ORF72-linked toxic species could allow for the design of targeted therapeutics that are specifically tailored toward disrupting their formation rather than affecting the downstream cascade of events. In particular, this would reduce the risk for unwanted side effects. Since DRP toxicity seems dependent on PR nuclear accumulation, perhaps an approach aimed selectively at preventing or breaking these nuclear aggregates would be more likely to succeed.
EXPERIMENTAL PROCEDURES Primary Neuronal Cultures and Transfections
Primary cortical/hippocampal neurons were prepared from embyronic day 19 (E19) rat embryos as previously described (Kayser et al., 2006) . Cortical neurons were plated at a density of 90,000/well on poly-D-lysine-and laminincoated 24-well plates or 12 mm coverslips. Hippocampal neurons were plated at a density of 25,000/well on poly-D-lysine-and laminin-coated 24-well plates or 12 mm coverslips. We added 5 mM Ara-C 3 days after plating to inhibit proliferation of dividing cells. Purified primary motor neurons were prepared from E14.5 rat embryos as previously described (Magrané et al., 2012) . Motor neurons were plated at a density of 15,000/well on poly-D,L-ornithine-and laminin-coated 24-well plates or coverslips. Cortical/hippocampal neurons were transfected using Lipofectamine 2000 at DIV10 (1 mg of total DNA/well), while motor neurons at DIV5-DIV7 (0.5 mg of total DNA/well). Synapsin-driven Td-Tomato reporter construct was cotransfected in cortical/hippocampal neurons and motor neurons with C9-related cDNA constructs at a ratio of 1:4.
Immunocytochemistry and Confocal Microscopy
Primary neuronal cultures were fixed in 3.6% PFA in PBS for 10 min at room temperature. Neurons were then permealized in 0.25% PBST for 15 min at room temperature and blocked in 1% BSA in PBST for 1 hr at room temperature, incubated with primary antibodies at 4 C overnight, secondary antibodies at room temperature for 1 hr, and mounted with anti-DAPI prolonggold anti-fade mounting media (Invitrogen). Neurons were washed with PBS three times between each step. The following primary antibodies were used: a-C9ORF72 (Sigma HPA023873, 1:200), a-Myc (Cell Signaling 2276, 1:1,000), a-TIAR (BD Transduction Laboratories 610352, 1:250), a-DCP1A (Sigma D5444, 1:500), a-Nucleolin (ProteinTech 10556-1-AP, 1:2,000), a-SMI32 (Covance SMI-32R, 1:1,000), a-MAP2 (Millipore AB5622, 1:500), a-Fibrillarin (SantaCruz sc-25397, 1:200), a-TU20 (Abcam ab7751 1:500), a-HB9 (DSHB 81.5C10, 1:5), a-Tuj1 (Millipore AB9354, 1:1,000), and a-PR (ProteinTech 23979-1-AP, 1:1,000). Cells were imaged using confocal microscopy (Olympus FV1000). We acquired six to ten images at a 0.3-mm-step size and projected onto one single image.
Longitudinal Live-Cell Imaging Analysis
For longitudinal live-cell imaging and neuronal survival analysis, we used an automated imaging system consisting of an inverted Nikon Eclipse Ti microscope equipped with PerfectFocus, a Tokai Hit stage top incubator with gas
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Quantification of Nucleoli and Processing Bodies
The number and size of P-bodies and nucleoli size were quantified with ImageJ software (NIH) using a manual and an automatic method. The manual method is based on the Cell Counter plugin to mark individual P-bodies by hand. Pbodies were counted based on size of fluorescence. The automatic method relied on an unbiased approach using a computational algorithm built in. Confocal images showing fluorescence of the soma and P-bodies were converted to 16-bit grayscale and the soma was traced to create boundaries for the analysis. Threshold of the image was then adjusted to highlight P-bodies and the background was subtracted to split overlapping P-bodies. The Pbodies were then analyzed using the Analyze Particles plugin with a minimum pixel size of 2. The average size of the P-bodies was also retrieved through this method. Overall, there was no significant difference between the manual and automatic methods. Nucleoli size was quantified by mean of the nucleolin fluorescence staining using the automatic method in the ImageJ software. The nucleus for each cell was traced for the boundaries and the area of the nucleus analyzed using the measure function. Using the same boundaries, the threshold of the image was then adjusted to highlight nucleolin fluorescence area and the background was subtracted. Nucleolin area was then analyzed using the Analyze Particles plugin with a minimum pixel size of 2. The measured nucleolin area was compared as a percentage of the nucleus area.
Fly Transgenesis and Experiments
Transgenic flies that carry GAL4-activatable genes encoding RAN proteins were generated by the BestGene. Eye expression, motor neuron expression, and muscle expression were induced by crossing C9RAN protein flies with the GMR GAL4 strain (Bloomington Stock Center), the OK371 GAL4 strain (Mahr and Aberle, 2006) , and the MHC GAL4 strain at 25 C, respectively.
Eye phenotype was scored and differences between the genotypes were assessed using one-way ANOVA and Scheffe's post hoc test. For the viability assay, C9RAN protein flies containing the TM6b balancer were crossed with OK371 GAL4 driver flies. Further details are provided in the Supplemental Experimental Procedures.
Statistics
For survival analysis, death was defined by the time at which a neuron was last imaged with intact neurites and no evidence of swollen soma or cell blebbing. Kaplan-Meier survival and Cox proportional hazards analysis were carried out using SPSS 19.0 software, while other statistical analysis was carried out using GraphPad Prism 6. Differences in Kaplan-Meier curves were assessed with the log-rank test. Comparisons between experimental groups in bar graphs were done by one-way ANOVA or t test as indicated. Data are expressed as average ± SEM. p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and eight figures and can be found with this article online at http://dx.doi. org/10.1016/j.neuron.2014.12.010.
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